Dr Reddy's Laboratories Ltd
NSE:DRREDDY

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Watchlist
Price: 1 341.35 INR -0.29% Market Closed
Market Cap: 1.1T INR
Have any thoughts about
Dr Reddy's Laboratories Ltd?
Write Note

Wall Street
Price Targets

DRREDDY Price Targets Summary
Dr Reddy's Laboratories Ltd

Wall Street analysts forecast DRREDDY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DRREDDY is 1 374.31 INR with a low forecast of 950.41 INR and a high forecast of 1 737.75 INR.

Lowest
Price Target
950.41 INR
29% Downside
Average
Price Target
1 374.31 INR
2% Upside
Highest
Price Target
1 737.75 INR
30% Upside
Dr Reddy's Laboratories Ltd Competitors:
Price Targets
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside
MYX
Mayne Pharma Group Ltd
36% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
22% Upside
600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
48% Upside
170900
Dong-A ST Co Ltd
52% Upside
AUROPHARMA
Aurobindo Pharma Ltd
25% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
21% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
43% Upside

Revenue
Forecast

Revenue Estimate
Dr Reddy's Laboratories Ltd

For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's revenue is 8%. The projected CAGR for the next 3 years is 8%.

8%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dr Reddy's Laboratories Ltd

For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's operating income is 10%. The projected CAGR for the next 3 years is -2%.

10%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Dr Reddy's Laboratories Ltd

For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's net income is 13%. The projected CAGR for the next 3 years is -4%.

13%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
-79%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DRREDDY's stock price target?
Price Target
1 374.31 INR

According to Wall Street analysts, the average 1-year price target for DRREDDY is 1 374.31 INR with a low forecast of 950.41 INR and a high forecast of 1 737.75 INR.

What is Dr Reddy's Laboratories Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's revenue is 8%. The projected CAGR for the next 3 years is 8%.

What is Dr Reddy's Laboratories Ltd's Operating Income forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's operating income is 10%. The projected CAGR for the next 3 years is -2%.

What is Dr Reddy's Laboratories Ltd's Net Income forecast?
Projected CAGR
-4%

For the last 8 years the compound annual growth rate for Dr Reddy's Laboratories Ltd's net income is 13%. The projected CAGR for the next 3 years is -4%.

Back to Top